Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlycoMimetics Incorporated
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy female subjects of non-childbearing potential or healthy male subjects who are between the ages of 18-45 years or 65 years of age or older.
Body mass index (BMI) of 17.5 to 40 kg/m2
You may not be if
Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at the time of dosing).
Pregnant females; breastfeeding female subjects; male subjects with partners currently pregnant
Treatment with another investigational drug within 30 days or 5 half-lives preceding the dose of study medication
Blood donation within 60 days prior to dosing.
Clareo Health | A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.
